Truncating mutations in the ACVR2 gene attenuates activin signaling in prostate cancer cells

Cancer Genetics and Cytogenetics

Volumn 163, Issue 2, 2005, Pages 123-129

  Rossi, Michael R ^a   Ionov, Yurij ^a   Bakin, Andrei V ^a   Cowell, John K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL ACTIVATION; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; INCIDENCE; MALE; MICROSATELLITE INSTABILITY; PANCREAS TUMOR; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN FUNCTION; RECEPTOR GENE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ACTIVIN RECEPTORS; ACTIVINS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION; HUMANS; MALE; MUTATION; PROSTATIC NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 28744441903     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.05.007     Document Type: Article

References (43)

1. Y. Shi, and J. Massague Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 2003 685 700
2. L.S. Mathews, and W.W. Vale Expression cloning of an activin receptor, a predicted transmembrane serine kinase Cell 65 1991 973 982
3. J. Massague TGF-beta signal transduction Ann Rev Biochem 67 1998 753 791
4. L. Attisano, J.L. Wrana, E. Montalvo, and J. Massague Activation of signaling by the activin receptor complex Mol Cell Bio 16 1996 1066 1073
5. J.J. Lebrun, and W.W. Vale Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation Mol Cell Biol 17 1997 1682 1691
6. C.A. Harrison, P.C. Gray, W.H. Fischer, C. Donaldson, S. Choe, and W. Vale An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors J Biol Chem 279 2004 28036 28044
7. J. Massague, S.W. Blain, and R.S. Lo TGFbeta signaling in growth control, cancer, and heritable disorders Cell 103 2000 295 309
8. G. Lagna, A. Hata, A. Hemmati-Brivanlou, and J. Massague Partnership between DPC4 and SMAD proteins in TGF-beta signaling pathways Nature 383 1996 832 836
9. R. Derynck, Y. Zhang, and X.H. Feng Smads: transcriptional activators of TGF-beta responses Cell 95 1998 737 740
10. J. Massague, and D. Wotton Transcriptional control by the TGF-beta/Smad signaling system EMBO J 19 2000 1745 1754
11. T.A. Tatusova, and T.L. Madden BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences FEMS Microbiol Lett 174 1999 247 250
12. Y. Ionov, M.A. Peinado, S. Malkhosyan, D. Shibata, and M. Perucho Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis Nature 363 1993 558 561
13. S. Markowitz, J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R.S. Fan, E. Zborowska, K.W. Kinzler, and B. Vogelstein Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability Science 268 1995 1336 1338
14. P.M. Hempen, L. Zhang, R.K. Bansal, C.A. Iacobuzio-Donahue, K.M. Murphy, A. Maitra, B. Vogelstein, R.H. Whitehead, S.D. Markowitz, J.K. Willson, C.J. Yeo, R.H. Hruban, and S.E. Kern Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers Cancer Res 63 2003 994 999
15. A. Olaru, Y. Mori, J. Yin, S. Wang, M.C. Kimos, K. Perry, Y. Xu, F. Sato, F.M. Selaru, E. Deacu, A. Sterian, D. Shibata, J.M. Abraham, and S.J. Meltzer Loss of heterozygosity and mutational analyses of the ACTRII gene locus in human colorectal tumors Lab Invest 83 2003 1867 1871
16. B. Jung, R.T. Doctolero, A. Tajima, A.K. Nguyen, T. Keku, R.S. Sandler, and J.M. Carethers Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers Gastroenterology 126 2004 654 659
17. K. Venkatasubbarao, M.M. Ahmed, C. Swiderski, C. Harp, E.Y. Lee, P. McGrath, M. Mohiuddin, W. Strodel, and J.W. Freeman Novel mutations in the polyadenine tract of the transforming growth factor beta type II receptor gene are found in a subpopulation of human pancreatic adenocarcinomas Genes Chromosomes Cancer 22 1998 138 144
18. F.H. D'Abronzo, B. Swearingen, A. Klibanski, and J.M. Alexander Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors J. Clin. Endocrinol Metab 84 1999 1716 1721
19. J.S. Jeruss, C.D. Sturgis, A.W. Rademaker, and T.K. Woodruff Down-regulation of activin, activin receptors, and smads in high-grade breast cancer Cancer Res 63 2003 3783 3790
20. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning: A Laboratory Manual 2nd ed. 1989 Cold Spring Harbor Laboratory Press New York, NY
21. A. Kumar, V. Novoselov, A.J. Celeste, N.M. Wolfman, P. ten Dijke, and M.R. Kuehn Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads J Biol Chem 276 2001 656 661
22. N. Bhattacharyya, J. Tao, E.A. Klein, and S. Banerjee Alterations of transforming growth factor beta receptor II, insulin growth factor receptor II genes in microsatellite unstable prostate carcinomas Oncol Rep 11 2004 231 236
23. L.E. Maquat Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics Nat. Rev. Mol. Cell Biol 5 2004 89 99
24. Y. Ionov, S. Matsui, and J.K. Cowell A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability Proc Natl Acad Sci USA 101 2004 1273 1278
25. R.M. Sramkoski, T.G. Pretlow 2nd, J.M. Giaconia, T.P. Pretlow, S. Schwartz, M.S. Sy, S.R. Marengo, J.S. Rhim, D. Zhang, and J.W. Jacobberger A new human prostate carcinoma cell line, 22Rv1 In Vitro Cell Dev Biol Anim 35 1999 403 409
26. Y. Guo, and N. Kyprianou Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells Cell Growth Differ 9 1998 185 193
27. W.L. Gerald Genome-wide gene expression analysis of prostate carcinoma Semin Oncol 30 2003 635 648
28. A. van Bokhoven, M. Varella-Garcia, C. Korch, W.U. Johannes, E.E. Smith, H.L. Miller, S.K. Nordeen, G.J. Miller, and M.S. Lucia Molecular characterization of human prostate carcinoma cell lines Prostate 57 2003 205 225
29. F. Liu, C. Pouponnot, and J. Massague Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes Genes Dev 11 1997 3157 3167
30. M.M. Matzuk, T.R. Kumar, and A. Bradley Different phenotypes for mice deficient in either activins or activin receptor type II Nature 374 1995 356 360
31. S. Shiozaki, T. Tajima, Y.Q. Zhang, M. Furukawa, Y. Nakazato, and I. Kojima Impaired differentiation of endocrine and exocrine cells of the pancreas in transgenic mouse expressing the truncated type II activin receptor Biochim Biophys Acta 1450 1999 1 11
32. F. Liu, L.E. Shao, and J. Yu Truncated activin type II receptor inhibits erythroid differentiation in K562 cells J Cell Biochem 78 2000 24 33
33. A. Maeshima, S. Shiozaki, T. Tajima, Y. Nakazato, T. Naruse, and I. Kojima Number of glomeruli is increased in the kidney of transgenic mice expressing the truncated type II activin receptor Biochem Biophys Res Commun 268 2000 445 449
34. D.W. Sehy, L.E. Shao, A.L. Yu, W.M. Tsai, and J. Yu Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylation of RB protein and the concomitant block of cell cycle at G1 phase J Cell Biochem 50 1992 255 265
35. S.J. Spencer, J. Rabinovici, and R.B. Jaffe Human recombinant activin-A inhibits proliferation of human fetal adrenal cells in vitro J Clin Endocrinol Metab 71 1990 1678 1680
36. S.D. Kundu, I.Y. Kim, T. Yang, L. Doglio, S. Lang, X. Zhang, R. Buttyan, S.J. Kim, J. Chang, X. Cai, Z. Wang, and C. Lee Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor Prostate 43 2000 118 124
37. W.H. Tu, T.Z. Thomas, N. Masumori, N.A. Bhowmick, A.E. Gorska, Y. Shyr, S. Kasper, T. Case, R.L. Roberts, S.B. Shappell, H.L. Moses, and R.J. Matusik The loss of TGF-beta signaling promotes prostate cancer metastasis Neoplasia 5 2003 267 277
38. Zhang Z, Zhao Y, Batres Y, Lin MF, Ying SY. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP. Biochem. Biophys. Res Commun 1997;234:362-65.
39. C.A. Heinlein, and C. Chang Androgen receptor in prostate cancer Endocr Rev 25 2004 276 308
40. S.A. Hayes, M. Zarnegar, M. Sharma, F. Yang, D.M. Peehl, P. ten Dijke, and Z. Sun Smad 3 represses androgen receptor-mediated transcription Cancer Res 61 2001 2112 2118
41. H.Y. Kang, H.K. Lin, Y.C. Hu, S. Yeh, K.E. Huang, and C. Chang From transforming growth factor ß signaling to androgen action: identification of Smad 3 as an androgen receptor coregulator in prostate cancer cells Proc Natl Acad Sci USA 98 2001 3018 3023
42. H.Y. Kang, K.E. Huang, S.Y. Chang, W.L. Ma, W.J. Lin, and C. Chang Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4 J Biol Chem 277 2002 43749 43756
43. R. Salovaara, S. Roth, A. Loukola, V. Launonen, P. Sistonen, E. Avizienyte, P. Kristo, H. Jarvinen, S. Souchelnytskyi, M. Sarlomo-Rikala, and L.A. Aaltonen Frequent loss of SMAD4/DPC4 protein in colorectal cancers Gut 51 2002 56 59